Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Cash Flow-to-Debt Ratio
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥1.25 Billion could theoretically repay 0% of its total liabilities (CN¥8.77 Billion) in one year. See 600866 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Starlake Bioscience Co Inc Zhaoqing Guangdong across 28 annual periods. Also explore 600866 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year debt coverage analysis for Starlake Bioscience Co Inc Zhaoqing Guangdong. For market capitalisation and broader financial context, see Starlake Bioscience Co Inc Zhaoqing Guan stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥1.29 Billion | CN¥8.79 Billion | ▼ -60.0% |
| 2024 | 0.37x | CN¥2.40 Billion | CN¥6.52 Billion | ▲ +22.1% |
| 2023 | 0.30x | CN¥2.03 Billion | CN¥6.73 Billion | ▲ +64.3% |
| 2022 | 0.18x | CN¥1.66 Billion | CN¥9.07 Billion | ▼ -33.6% |
| 2021 | 0.28x | CN¥192.63 Million | CN¥697.74 Million | ▼ -16.8% |
| 2020 | 0.33x | CN¥249.99 Million | CN¥752.97 Million | ▼ -7.2% |
| 2019 | 0.36x | CN¥213.17 Million | CN¥595.95 Million | ▲ +245.0% |
| 2018 | 0.10x | CN¥50.69 Million | CN¥488.94 Million | ▲ +38.4% |
| 2017 | 0.07x | CN¥40.05 Million | CN¥534.57 Million | ▲ +16.1% |
| 2016 | 0.06x | CN¥41.17 Million | CN¥637.90 Million | ▲ +1771.0% |
| 2015 | 0.00x | CN¥2.75 Million | CN¥795.88 Million | ▲ +113.4% |
| 2014 | -0.03x | CN¥-20.22 Million | CN¥787.37 Million | ▼ -3.8% |
| 2013 | -0.02x | CN¥-28.16 Million | CN¥1.14 Billion | ▲ +84.8% |
| 2012 | -0.16x | CN¥-276.02 Million | CN¥1.70 Billion | ▼ -499.7% |
| 2011 | 0.04x | CN¥65.88 Million | CN¥1.62 Billion | ▼ -72.9% |
| 2010 | 0.15x | CN¥104.63 Million | CN¥698.07 Million | ▼ -77.4% |
| 2009 | 0.66x | CN¥316.73 Million | CN¥477.36 Million | ▲ +158.6% |
| 2008 | 0.26x | CN¥148.93 Million | CN¥580.44 Million | ▲ +89.4% |
| 2007 | 0.14x | CN¥82.28 Million | CN¥607.29 Million | ▲ +99.3% |
| 2006 | 0.07x | CN¥35.14 Million | CN¥516.89 Million | ▼ -28.9% |
| 2005 | 0.10x | CN¥46.83 Million | CN¥489.57 Million | ▲ +35.3% |
| 2004 | 0.07x | CN¥29.05 Million | CN¥410.86 Million | ▼ -87.4% |
| 2003 | 0.56x | CN¥149.70 Million | CN¥266.82 Million | ▼ -42.1% |
| 2002 | 0.97x | CN¥183.18 Million | CN¥188.89 Million | ▲ +292.2% |
| 2001 | 0.25x | CN¥60.82 Million | CN¥245.97 Million | ▼ -12.2% |
| 2000 | 0.28x | CN¥93.41 Million | CN¥331.53 Million | ▼ -23.5% |
| 1999 | 0.37x | CN¥52.97 Million | CN¥143.87 Million | ▼ -14.3% |
| 1998 | 0.43x | CN¥71.14 Million | CN¥165.54 Million | — |